HCPLive Network
  • CDC Chief Says Ebola Outbreak is Worse than Feared
  • Chronic Pain Peer Exchange Video Series
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Healthcare workers in poor nations often do not have enough protective gear to keep them safe from being infected with blood-borne viruses such as Ebola and HIV, according to a study published online Aug. 8 in Tropical Medicine & International Health.
By Adam Hochron
For patients with hypertension, finding the right course of treatment can be critically important especially when other health factors are taken into consideration.
By Laura Joszt
Although previous research has found probiotics can prevent antibiotic-associated diarrhea (AAD) and Clostridium difficile diarrhea (CDD), a study from researchers in the United Kingdom and Germany reported contradicting results.
By Gale Scott
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
By Rachel Lutz
Peripheral neuropathy was found in a third of HIV patients in a recent study of 58 men with a median age of 36 years.
By Rachel Lutz
Men who are socially well-integrated show more than a 2-fold reduced risk of suicide, according to a longitudinal study published in the Annals of Internal Medicine.
By Adam Hochron
When a patient gets bitten by a dog, there can be many issues doctors need to confront as treatment begins. Two doctors shared their experiences of a patient who was bitten by a dog and still had symptoms including swelling and pain 2 weeks after his K-9 encounter.
A prognostic model has been developed and validated which has adequate discrimination for major outcomes in type 1 diabetes, according to a study published online Aug. 28 in Diabetologia.
High sodium intake is associated with increased disease activity in multiple sclerosis, according to research published online Aug. 28 in the Journal of Neurology, Neurosurgery & Psychiatry.
By Jacquelyn Gray
The costs of Medicare associated with Sovaldi (sofosbuvir), an emerging hepatitis C drug, will vary depending on how many people are given the treatment, a blog in Health Affairs found.
Email Signup
Breaking News
GlaxoSmithKline's Arnuity approved for patients over the age of 12 as part of treatment options
Researchers from the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline will soon launch phase I clinical trials of experimental Ebola vaccines.
Physician's Money Digest
If there is one lesson investors learn, it should be to avoid being bearish for too long. Otherwise, you miss out on some incredible investment runs on Wall Street.
One accountable care organization saved $8.5 million and received a check from Medicare for $4.2 million after 17 months. Suddenly, they had physicians clamoring to join.
Product News
The European Commission (EU) has granted Bristol-Myers Squibb’s Daklinza (daclatasvir) approval for an all-oral drug regimen for the treatment of four genotypes of chronic hepatitis C infection.
An investigational drug that researchers hope will reverse nerve damage in patients with multiple sclerosis (MS) has been found to be safe and well tolerated in early trials. The big question is whether it will work, researchers said.
The US Food and Drug Administration announced it will give priority review status to Amgen’s application to market ivabradine as a treatment for chronic heart failure.
Clinicians who treat patients suffering with osteoarthritis pain have a new low-dose nonsteroidal anti-inflammatory drug (NSAID) option at their disposal. Zorvolex (diclofenac) was developed to meet prevailing FDA recommendations regarding NSAID dosing and treatment duration.
One-pill regiment includes abacavir, dolutegravir and lamivudine.